1:12:30South Africa Tests AIDS Vaccine
From the creator
This is the VOA Special English Health Report. Thirty-six volunteers in South Africa will test the safety of an African-developed vaccine against H.I.V. The tests are the first step in human clinical trials of two vaccine candidates developed at the University of Cape Town. These experimental AIDS vaccines are the first from Africa to reach testing in people. The National Institutes of Health in the United States provided assistance. Testing with twelve people began earlier this year in Boston, Massachusetts. South Africa has more than five million people infected with H.I.V., the largest number of any country. South Africa officially launched the tests in July as the International AIDS Society held a conference in Cape Town. Other human trials of possible vaccines are taking place around the world. But during the conference, experts reported the first decrease in international financing for AIDS vaccine research. They say funding dropped from about nine hundred thirty million dollars in two thousand seven to eight hundred seventy million last year. Also at the conference, scientists presented the latest findings about new mothers infected with H.I.V. Two studies showed ways in which anti-H.I.V. drugs could permit infected women to breastfeed their newborns with less risk of passing the virus to them. The research was done in Cameroon, Ivory Coast, South Africa and Zambia. In one study, infected mothers began to take three anti-H.I.V. drugs while breastfeeding
Published 2009-09-02 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





